GlassScriptPhysician profile
Morteza Yavari
NPI 1568452126
$2,555.61
in general payments reported to CMS, 2019-2025
14 companies · $284 in 2025
The $284 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $89.79 · 2022: $394 · 2023: $162 · 2024: $319 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $454.26 | 2019-2024 | Titan |
| Janssen Biotech, INC. | $320.36 | 2019-2020 | |
| Astellas Pharma US INC | $275.60 | 2019 | |
| Boston Scientific Corporation | $213.03 | 2019 | |
| Bioprotect Medical, INC. | $159.93 | 2025 | Bioprotect Balloon Implant System |
| Teleflex LLC | $150.92 | 2022-2024 | Urolift |
| Karl Storz Endoscopy-America | $141.42 | 2019 | |
| Olympus America INC. | $134.01 | 2024 | Itind System |
| Profound Medical Corp. | $133.70 | 2022 | |
| Axonics, INC. | $126.00 | 2022 | |
| Calyxo, INC. | $124.05 | 2025 | Cvac Aspiration System |
| Conmed Corporation | $122.73 | 2019 | |
| Medical Device Business Services, INC. | $117.48 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $82.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morteza Yavari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.